Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)
5,940.00
+50.00 (0.85%)
Last updated: Jun 27, 2025
Kwang Dong Pharmaceutical Revenue
Kwang Dong Pharmaceutical had revenue of 377.60B KRW in the quarter ending March 31, 2025, a decrease of -8.46%. This brings the company's revenue in the last twelve months to 1.61T, up 2.28% year-over-year. In the year 2024, Kwang Dong Pharmaceutical had annual revenue of 1.64T with 8.34% growth.
Revenue (ttm)
1,605.84B
Revenue Growth
+2.28%
P/S Ratio
0.14
Revenue / Employee
1.56B
Employees
1,032
Market Cap
225.86B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,640.72B | 126.26B | 8.34% |
Dec 31, 2023 | 1,514.45B | 82.91B | 5.79% |
Dec 31, 2022 | 1,431.55B | 93.36B | 6.98% |
Dec 31, 2021 | 1,338.18B | 94.41B | 7.59% |
Dec 31, 2020 | 1,243.77B | 5.51B | 0.45% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
KT&G Corporation | 6,107.64B |
Samyang Foods | 1,871.28B |
Amorepacific | 4,041.17B |
APR Co., Ltd. | 839.86B |
LG H&H | 6,781.09B |
ORION | 3,157.72B |
CJ Cheiljedang | 29.35T |
Cosmax | 2,227.86B |